Fat intake reduction strategies among children and adults to eliminate obesity and non-communicable diseases in the eastern mediterranean region

Children

Volumn 5, Issue 7, 2018, Pages

  Jawaldeh, Ayoub Al ^a   Al Jawaldeh, Hanin ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b AMERICAN UNIVERSITY OF MADABA   (Jordan)

Author keywords

Eastern Mediterranean region; Fat; NCD; SFAs; TFAs

Indexed keywords

EID: 85061195205     PISSN: None     EISSN: 22279067     Source Type: Journal    
DOI: 10.3390/children5070089     Document Type: Review

References (80)

1. World Health Organization. Global Status Report on Noncommunicable Diseases 2014; World Health Organization: Geneva, Switzerland, 2014; Available online: http://apps.who.int/iris/handle/10665/148114 (accessed on 18 January 2018).
2. World Health Organization; Regional Office for the Eastern Mediterranean (EMRO). Eastern Mediterranean Region Framework for Health Information Systems and Core Indicators for Monitoring Health Situation and Health System Performance. 2017. Available online: http://applications.emro.who.int/docs/EMROPUB_ 2017_EN_16766.pdf?ua=1 (accessed on 15 January 2018).
3. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017, 390, 1151–1210.
4. World Health Organization Regional; Office for the Eastern Mediterranean (EMRO). Health Systems Strengthening in Countries of the Eastern Mediterranean Region: Challenges, Priorities and Options for Future Action; EMRO: Cairo, Egypt, 2012; Available online: http://apps.who.int/iris/handle/10665/123147 (accessed on 1 April 2018).
5. Alwan, A.; McColl, K.; James, J.P.; Al-Jawaldeh, A. Proposed Policy Priorities for Preventing Obesity and Diabetes in the Eastern Mediterranean Region; EMRO: Cairo, Egypt, 2017; Available online: http://www.who.int/iris/handle/10665/259519 (accessed on 10 March 2018).
6. World Health Organization. Global Observatory (GHO) Data. Available online: http://www.who.int/gho/en/(accessed on 10 May 2018).
7. World Health Organization, Global Health Observatory Data Repository. Raised Total Cholesterol (≥5.0 mmol/L): Data by Country. Available online: http://apps.who.int/gho/data/view.main.2467 (accessed on 10 March 2018).
8. Lichtenstein, A.H. Dietary trans fatty acids and cardiovascular disease risk: Past and present. Curr. Atheroscler. Rep. 2014, 16, 433. [CrossRef] [PubMed]
9. Mozaffarian, D.; Clarke, R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur. J. Clin. Nutr. 2009, 63, S22. [CrossRef] [PubMed]
10. Sun, Q.; Ma, J.; Campos, H.; Hankinson, S.E.; Manson, J.E.; Stampfer, M.J.; Rexrode, K.M.; Willett, W.C.; Hu, F.B. A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 2007, 115, 1858–1865. [CrossRef] [PubMed]
11. World Health Organization. Diet, Nutrition and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation; World Health Organization: Geneva, Switzerland, 2003; Available online: http://whqlibdoc. who.int/trs/WHO_TRS_916.pdf (accessed on 1 February 2018).
12. Wang, Q.; Afshin, A.; Yakoob, M.Y.; Singh, G.M.; Rehm, C.D.; Khatibzadeh, S. Impact of nonoptimal intakes of saturated, polyunsaturated, and trans fat on global burdens of coronary heart disease. J. Am. Heart Assoc. 2016, 5, e002891. [CrossRef] [PubMed]
13. Welty, F.K. How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis? Curr. Cardiol. Rep. 2013, 15, 400. [CrossRef] [PubMed]
14. Bhardwaj, S.; Passi, S.J.; Misra, A. Overview of trans fatty acids: Biochemistry and health effects. Diabetes Metab. Syndr. 2011, 5, 161–164. [CrossRef] [PubMed]
15. Farvid, M.S.; Ding, M.; Pan, A.; Sun, Q.; Chiuve, S.E.; Steffen, L.M.; Willett, W.C.; Hu, F.B. Dietary linoleic acid and risk of coronary heart disease: A systematic review and meta-analysis of prospective cohort studies. Circulation 2014, 130, 1568–1578. [CrossRef] [PubMed]
16. Melanson, E.L.; Astrup, A.; Donahoo, W.T. The relationship between dietary fat and fatty acid intake and body weight, diabetes, and the metabolic syndrome. Ann. Nutr. Metab. 2009, 55, 229–243. [CrossRef] [PubMed]
17. Micha, R.; Mozaffarian, D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: A fresh look at the evidence. Lipids 2010, 45, 893–905. [CrossRef] [PubMed]
18. Chowdhury, R.; Warnakula, S.; Kunutsor, S.; Crowe, F.; Ward, H.A.; Johnson, L.; Franco, O.H.; Butterworth, A.S.; Forouhi, N.G.; Thompson, S.G.; et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: A systematic review and meta-analysis. Ann. Intern. Med. 2014, 160, 398–406. [CrossRef] [PubMed]
19. Dashti, B.; Al-Awadi, F.; Sawaya, W.; Al-Otaibi, J.; Al-Sayegh, A. Fatty acid profile and cholesterol content of 32 selected dishes in the state of Kuwait. Food Chem. 2003, 80, 377–386. [CrossRef]
20. Anzid, K.; Baali, A.; Vimard, P.; Levy-Desroches, S.; Cherkaoui, M.; López, P.M. Inadequacy of vitamins and minerals among high-school pupils in Ouarzazate, Morocco. Public Health Nutr. 2014, 17, 1796–1795. [CrossRef] [PubMed]
21. Smit, L.A.; Mozaffarian, D.; Willett, W. Review of fat and fatty acid requirements and criteria for developing dietary guidelines. Ann. Nutr. Metab. 2009, 55, 44–55. [CrossRef] [PubMed]
22. World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks; World Health Organization: Geneva, Switzerland, 2009.
23. Jakicic, J.M.; Ard, J.D.; de Jesus, J.M.; Houston Miller, N.; Hubbard, V.S.; Lee, I.M.; Lichtenstein, A.H.; Loria, C.M.; Millen, B.E.; Nonas, C.A.; et al. AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. Circulation 2013, 129, S76–S99.
24. Mozaffarian, D.; Katan, M.B.; Ascherio, A.; Stampfer, M.J.; Willett, W.C. Trans fatty acids and cardiovascular disease. N. Engl. J. Med. 2006, 354, 1601–1613. [CrossRef] [PubMed]
25. Stachowska, E.; Dołegowska, B.; Olszewska, M.; Gutowska, I.; Chlubek, D. Isomers of trans fatty acids modify the activity of platelet 12-P lipoxygenase and cyclooxygenase/thromboxane synthase. Nutrition 2004, 20, 570–571. [CrossRef] [PubMed]
26. Bray, G.A.; Lovejoy, J.C.; Smith, S.R.; DeLany, J.P.; Lefevre, M.; Hwang, D.; Ryan, D.H.; York, D.A. The influence of different fats and fatty acids on obesity, insulin resistance and inflammation. J. Nutr. 2002, 132, 2488–2491. [CrossRef] [PubMed]
27. Risérus, U.; Willett, W.C.; Hu, F.B. Dietary fats and prevention of type 2 diabetes. Prog. Lipid Res. 2009, 48, 44–51. [CrossRef] [PubMed]
28. Salmeron, J.; Hu, F.B.; Manson, J.E.; Stampfer, M.J.; Colditz, G.A.; Rimm, E.B.; Willett, W.C. Dietary fat intake and risk of type 2 diabetes in women. Am. J. Clin. Nutr. 2001, 73, 1019–1026. [CrossRef] [PubMed]
29. Kavanagh, K.; Jones, K.L.; Sawyer, J.; Kelley, K.; Carr, J.J.; Wagner, J.D.; Rudel, L.L. Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Obesity 2007, 15, 1675–1684. [CrossRef] [PubMed]
30. Simopoulos, A.P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. 2008, 233, 674–688. [CrossRef] [PubMed]
31. Innis, S.M. Trans fatty intakes during pregnancy, infancy and early childhood. Atheroscler. Suppl. 2006, 7, 17–20. [CrossRef] [PubMed]
32. FAO/WHO. Interim Summary of Conclusions and Dietary Recommendations on Total Fat and Fatty Acids. Joint FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition. 2010. Available online: http://www.who.int/nutrition/topics/FFA_summary_rec_conclusion.pdf (accessed on 12 March 2017).
33. Siri-Tarino, P.W.; Sun, Q.; Hu, F.B.; Krauss, R.M. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am. J. Clin. Nutr. 2010, 91, 535–546. [CrossRef] [PubMed]
34. WHO Regional Office for Europe Nutrient Profile Model. Copenhagen: World Health Organization Regional Office for Europe. 2015. Available online: http://www.euro.who.int/__data/assets/pdf_file/0005/270716/Nutrient-children_web-new.pdf (accessed on 30 March 2018).
35. Ascherio, A.; Hennekens, C.H.; Buring, J.E.; Master, C.; Stampfer, M.J.; Willett, W.C. Trans-fatty acids intake and risk of myocardial infarction. Circulation 1994, 89, 94–101. [CrossRef] [PubMed]
36. Willett, W.C.; Stampfer, M.J.; Manson, J.E.; Colditz, G.A.; Speizer, F.E.; Rosner, B.A.; Sampson, L.A.; Hennekens, C.H. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993, 341, 581–585. [CrossRef]
37. Kandhro, A.; Sherazi, S.T.; Mahesar, S.A.; Bhanger, M.I.; Talpur, M.Y.; Rauf, A. GC-MS quantification of fatty acid profile including trans FA in the locally manufactured margarines of Pakistan. Food Chem. 2008, 109, 207–211. [CrossRef] [PubMed]
38. World Health Organization. The Political Declaration of the United Nations General Assembly on the Prevention and Control of Non-Communicable Diseases: Commitments of Member States and the Way Forward. 2012 EM/RC59/R.2. Available online: http://applications.emro.who.int/docs/RC_Resolutions_ 20122_14692_EN.pdf?ua=1 (accessed on 1 March 2017).
39. World Health Organization. Implementing the United Nations Political Declaration on Prevention and Control of Noncommunicable Diseases Based on the Regional Framework for Action. Regional Committee for the Eastern Mediterranean Sixtieth Session Provisional Agenda Item 7. EM/RC60/9 Rev.1 September 2013. Available online: http://applications.emro.who.int/docs/RC_Techn_paper_2013_9_15001_EN.pdf (accessed on 1 April 2018).
40. Food and Agriculture Organization (FAOSTAT). Supply Utilization Accounts and Food Balances Domain: Food Balance Sheets. 2014. Available online: http://faostat3.fao.org/download/FB/FBS/E (accessed on 10 April 2017).
41. Food and Agriculture Organization of the United Nations. Food and Nutrition in Numbers 2014. 2014. Available online: http://coin.fao.org/coin-static/cms/media/22/14163487981020/food_and_nutrition_ in_numbers.pdf (accessed on 10 March 2017).
42. Micha, R.; Khatibzadeh, S.; Shi, P. Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: A systematic analysis including 266 country-specific nutrition surveys. BMJ 2014, 348. [CrossRef] [PubMed]
43. Kandhro, A.; Sherazi, S.T.; Mahesar, S.A.; Bhanger, M.I.; Talpur, M.Y.; Arain, S. Monitoring of fat content, free fatty acid and fatty acid profile including trans fat in Pakistani biscuits. J. Am. Oil Chem. Soc. 2008, 85, 1057–1061. [CrossRef]
44. Mahesar, S.; Kandhro, A.A. Determination of total trans fat content in Pakistani cereal-based foods by SB-HATR FT-IR spectroscopy coupled with partial least square regression. Food Chem. 2010, 123, 1289–1293. [CrossRef]
45. Hajimahmoodi, M.; Arami, S.; Nosrati, M. Trans Fatty Acid Content of Iranian Edible Oils. Food Nutr. Sci. 2013, 4, 1167–1174. [CrossRef]
46. Ministry of Health. Unpublished Report on the Fat Profile for Food Products; Ministry of Health: Rabat, Morocco, 2015.
47. Bakeet, Z.A.N.; Alobeidallah, F.M.; Arzoo, S. Fatty acid composition with special emphasis on unsaturated trans fatty acid content in margarines and shortenings marketed in Saudi Arabia. Int. J. Biosci. 2013, 3, 86–93.
48. National Nutrition Institutes. Unpublished Report Data on Food Consumption Pattern; National Nutrition Institutes: Tunis, Tunisia, 2015.
49. Nasreddine, L.; Naja, F.A.; Sibai, A.M.; Helou, K.; Adra, N.; Hwalla, N. Trends in nutritional intakes and nutrition-related cardiovascular disease risk factors in Lebanon: The need for immediate action. Leban. Med. J. 2013, 62, 83–91. [CrossRef]
50. Mashal, R. Variability in trans fatty acid content of selected local and imported foods in Jordan. Riv. Ital. Delle Sostanze Grasse 2011, 89, 193–200.
51. Karim, Z.; Khan, K.M.; Ahmed, S.; Karim, A. Assessment of Trans Fatty Acid Level in French Fries from Various Fast Food Outlets in Karachi, Pakistan. J. Am. Oil Chem. Soc. 2014, 91, 1831–1836. [CrossRef]
52. Nazari, B.; Asgary, S.; Azadbakht, L. Fatty acid analysis of Iranian junk food, dairy, and bakery products: Special attention to trans-fats. J. Res. Med. Sci. 2012, 17, 952–957. [PubMed]
53. National Institute of Nutrition Food and Technology Food. Tunisian Food Composition Table of the Tunisian, 7th ed.; National Institute of Nutrition Food and Technology Food: Tunis, Tunisia, 1994.
54. Takruri, H.R.; Alkurd, R.A. Intakes of Fats, Cholesterol, Fiber and Micronutrients as Risk Factors for Cardiovascular Disease in Jordan. Jordan J. Biol. Sci. 2014, 7, 119–126. [CrossRef]
55. Nazari, B.; Asgary, S.; Sarrafzadegan, N. Warning about Fatty Acid Compositions in Some Iranian Mayonnaise Salad Dressings. Int. J. Prev. Med. 2010, 1, 110–114. [PubMed]
56. Rifat-uz-Zaman, Z.I.; Ali, U. Dietary Intakes of Urban Adolescents of Sialkot, Pakistan Do Not Meet the Standards of Adequacy. Pak. J. Nutr. 2013, 12, 460–467. [CrossRef]
57. Zaghloul, S.; Al-Hooti, S.N.; Al-Hamad, N.; Al-Zenki, S.; Alomirah, H.; Alayan, I.; Al-Attar, H.; Al-Othman, A.; Al-Shami, E.; Al-Somaie, M.; et al. Evidence for nutrition transition in Kuwait: Over-consumption of macronutrients and obesity. Public Health Nutr. 2013, 16, 596–607. [CrossRef] [PubMed]
58. Bahadoran, Z.; Mirmiran, P.; Golzarand, M.; Hosseini-Esfahani, F.; Azizi, F. Fast food consumption in Iranian adults; dietary intake and cardiovascular risk factors: Tehran Lipid and Glucose Study. Arch. Iran. Med. 2012, 15, 346–351. [PubMed]
59. Asgary, S.; Nazari, B.; Sarrafzadegan, N.; Parkhideh, S.; Saberi, S.; Esmaillzadeh, A.; Azadbakht, L. Evaluation of fatty acid content of some Iranian fast foods with emphasis on trans fatty acids. Asia Pac. J. Clin. Nutr. 2009, 18, 187–189. [PubMed]
60. Gharib, N.; Rasheed, P. Energy and macronutrient intake and dietary pattern among school children in Bahrain: A cross-sectional study. Nutr. J. 2011, 10, 62. [CrossRef] [PubMed]
61. Gharib, N.M.; Rasheed, P. Obesity among Bahraini Children and Adolescents: Prevalence and Associated Factors. J. Bahrain Med. Soc. 2013, 20, 401–407.
62. Oomen, C.M.; Ocké, M.C.; Feskens, E.J.; van Erp-Baart, M.A.; Kok, F.J.; Kromhout, D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: A prospective population-based study. Lancet 2001, 357, 746–751. [CrossRef]
63. Pirjo, P.; Vartiainen, E.; Seppänen, R.; Aro, A.; Puska, P. Changes in Diet in Finland from 1972 to 1992: Impact on Coronary Heart Disease Risk. Prev. Med. 1996, 25, 243–250.
64. World Health Organization. WHO Regional Office for Europe. Eliminating Trans Fats in Europe: A Policy Brief. 2015. Available online: http://www.euro.who.int/__data/assets/pdf_file/0010/288442/Eliminating-trans-fats-in-Europe-A-policy-brief.pdf (accessed on 10 April 2017).
65. Danish Academy of Technical Sciences, ATV. Economic Nutrition Policy Tools—Useful in the Challenge to Combat Obesity and Poor Nutrition? December 2007. Available online: https://atv.dk/sites/atv.dk/files/media/document/Rapport_ATV_Economic_nutrition_policy_tools_December_2007.pdf (accessed on 1 May 2018).
66. Jakobsen, M.U.; O’Reilly, E.J.; Heitmann, B.L.; Pereira, M.A.; Balter, K.; Fraser, G.E. Major types of dietary fat and risk of coronary heart disease: A pooled analysis of 11 cohort studies. Am. J. Clin. Nutr. 2009, 89, 1425–1432. [CrossRef] [PubMed]
67. Tutino, V.; Caruso, M.G.; De Leonardis, G.; De Nunzio, V.; Notarnicola, M. Tissue Fatty Acid Profile is Differently Modulated from Olive Oil and Omega-3 Polyunsaturated Fatty Acids in ApcMin/+ Mice. Endocr. Metab. Immune Disord.-Drug Targets 2017, 17, 303–308. [CrossRef] [PubMed]
68. General Assembly of the United Nations. Political Declaration of the High-Level Meeting of the General Assembly on the Prevention and Control of Non-Communicable Diseases; United Nations: New York, NY, USA, 2011.
69. Krenosky, S.; Mary, L.; Nora, L.; Lynne, U.; Michel, V. Risk Assessment of Exposure to Trans Fat in Canada. Int. Food Risk Anal. J. 2012, 2, 1–15. [CrossRef]
70. World Health Organization. A Review of Nutrition Policies: Draft Report; World Health Organization: Geneva, Switzerland, 2010; Available online: http://www.who.int/nutrition/EB128_18_Backgroundpaper1_A_ review_of_nutritionpolicies.pdf (accessed on 6 May 2013).
71. WHO Regional Office for the Eastern Mediterranean (EMRO). Assessing National Capacity for the Prevention and Control of Noncommunicable Diseases; EMRO: Cairo, Egypt, 2016; Available online: http://apps.who.int/iris/bitstream/1/250370/10665/EMROPUB_2016_EN_19168.pdf (accessed on 1 April 2018).
72. World Health Organization. Report on the Technical Consultation on Salt and Fat Reduction Strategies in the Eastern Mediterranean Region; World Health Organization: Tunis, Tunisia, 30–31 March 2015; Available online: http://applications.emro.who.int/docs/IC_Meet_Rep_2015_EN_16339.pdf (accessed on 1 March 2018).
73. GCC Standardization Organization. Trans Fatty Acids GSO 2483. 2015. Available online: https://www.gso. org.sa/store/gso/standards/GSO:693058/GSO%202483:2015?lang=en (accessed on 1 May 2018).
74. WHO. Moving Forward on Salt and Fat Reduction in the Region. East. Mediterr. Health J. 2015, 21, 374–376.
75. World Health Organization. Policy Statement and Recommended Actions for Reducing Fat Intake and Lowering Heart Attack Rates in the Eastern Mediterranean Region; World Health Organization: Geneva, Switzerland, 2014; Available online: http://www.emro.who.int/nutrition/strategy/policy-statement-2013.html (accessed on 10 April 2017).
76. World Health Organization. Global Database on the Implementation of Nutrition Action (GINA); World Health Organization: Geneva, Switzerland, 2012; Available online: http://www.who.int/nutrition/gina/en/(accessed on 15 March 2017).
77. Peymani, P.; Joulaei, H.; Lankarani, K.B. Iran’s Experience on Reduction of Trans-Fatty Acid Content in Edible Oils. Middle-East J. Sci. Res. 2012, 11, 1207–1211.
78. GCC Standardization Organization. The Technical Regulation GSO 9/2013 “Labeling of Prepackaged Foodstuffs”. Available online: https://www.gso.org.sa/store/gso/standards/GSO:615544/GSO%209: 2013?lang=en (accessed on 30 March 2018).
79. World Health Organization. An Action Package to Eliminate Industrially-Produced Trans Fat from the Global Food Supply; World Health Organization: Geneva, Switzerland, 2018; Available online: http://www.who. int/nutrition/topics/replace-transfat (accessed on 15 March 2018).
80. Rayner, M.; Scarborough, P.; Kaur, A. Nutrient profiling and the regulation of marketing to children. Possibilities and pitfalls. Appetite 2013, 62, 232–235. [CrossRef] [PubMed]